Keyphrases
Pseudomonas Aeruginosa (P. aeruginosa)
100%
Cystic Fibrosis
71%
Biofilm
59%
Denmark
40%
Antibiotics
34%
Pseudomonas Aeruginosa Biofilm
22%
Escherichia Coli
18%
Biofilm Infection
18%
Staphylococcus Aureus
17%
Chronic Infection
16%
Lung
16%
Infective Endocarditis
16%
European Committee on Antimicrobial Susceptibility Testing (EUCAST)
16%
Lung Infection
15%
National Cohort Study
15%
COVID-19
14%
Confidence Interval
14%
Ciprofloxacin
14%
Antibiotic Treatment
14%
Antibiotic Resistance
13%
Quorum Sensing
12%
Biofilm Formation
11%
Bacteremia
11%
Chronic Wounds
10%
Urinary Tract Infection
10%
Bloodstream Infection
10%
Bacterial Biofilm
10%
Airway
9%
Risk Factors
9%
Malaria
9%
Ghana
8%
Polymorphonuclear Leukocytes
8%
Antimicrobial
8%
Susceptibility Testing
8%
Cerebral Malaria
8%
Tobramycin
8%
Chronic Lung Infection
7%
Endocarditis
7%
Antimicrobial Resistance
7%
Colistin
7%
Quantitative PCR
6%
Microorganisms
6%
Epidemiology
6%
Plasmodium Falciparum
6%
Europe
6%
Bacterial Infection
6%
Whole Genome Sequencing
6%
Immune Response
6%
Candidemia
6%
Copenhagen
6%
Inflammation
6%
Candida
6%
C.glabrata
5%
Adaptation
5%
Antifungal Susceptibility
5%
Blood Culture
5%
Sputum
5%
Hyperbaric Oxygen Therapy
5%
Infection Model
5%
Voriconazole
5%
Echinocandins
5%
Enterococcus Faecium
5%
Opportunistic Pathogens
5%
Ghanaian children
5%
Cytomegalovirus
5%
Antibiotic Therapy
5%
Falciparum Malaria
5%
Azole Resistance
5%
Immunology and Microbiology
Pseudomonas aeruginosa
97%
Biofilm
73%
Infectious Agent
30%
Minimum Inhibitory Concentration
24%
Escherichia coli
22%
Staphylococcus Aureus
17%
Antimicrobial Resistance
16%
Mouse
15%
Quorum Sensing
14%
Prevalence
13%
Candida
11%
Plasmodium falciparum
10%
Wild Type
10%
Urinary Tract
9%
Microorganism
9%
Granulocyte
9%
Neutrophil Granulocyte
9%
Endocarditis
9%
Candida Albicans
7%
Immune Response
7%
Sputum
7%
Human Immunodeficiency Virus
7%
Whole Genome Sequencing
7%
Polymerase Chain Reaction
7%
Aspergillus
7%
Surface Property
7%
Lineages
6%
Monospecific Antibody
6%
Aspergillus fumigatus
6%
Dynamics
5%
Colistin
5%
Antifungal Susceptibility
5%
Antibiotic Sensitivity
5%
Medicine and Dentistry
Infection
47%
Cohort Analysis
21%
Cystic Fibrosis
21%
Pseudomonas aeruginosa
18%
Antibiotics
18%
Pathogen
10%
Disease
10%
Antibiotic Therapy
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Diagnosis
9%
Patient with Cystic Fibrosis
8%
Infective Endocarditis
8%
Bloodstream Infection
8%
In Vitro
8%
Lung Infection
6%
Antibiotic Resistance
6%
Prevalence
6%
Bacteremia
5%
Wound
5%
COVID-19
5%
Polymerase Chain Reaction
5%
Antifungal Agent
5%
Endocarditis
5%